Halozyme Therapeutics Inc. Common Stock vs KraneShares Hang Seng TECH Index ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $109.92 (market cap $12.58B), while KraneShares Hang Seng TECH Index ETF trades at $11.67 (market cap $45.04M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 279.3× KraneShares Hang Seng TECH Index ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and KraneShares Hang Seng TECH Index ETF for 44 Days on average.
| HALO | KTEC | |
|---|---|---|
Market Cap | $12.58B | $45.04M |
Volume | 2,179,278 | 29,043 |
Sector | Health | Sector/Thematic |
52-Week High | $115.22 | $18.73 |
52-Week Low | $61.63 | $11.41 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $14.49B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →